Thalix 50 mg Capsule (Thalidomide)
| Brand Name | Thalix |
|---|---|
| Composition (Generic / INN) | Thalidomide |
| Strength | 50 mg |
| Packaging Size | 3*10 Capsules |
| Packaging Type | Box |
| Dosage Form | Capsule |
| Manufacturer | Fresenius Kabi |
| Prescription / Non-Prescription | Prescription |
| Usage / Indication | Used in combination with other medications to treat multiple myeloma and to treat skin symptoms associated with lepra reaction |
Thalix 50 mg Capsule – Thalidomide by Fresenius Kabi
Thalix 50 mg Capsule contains Thalidomide and is manufactured by Fresenius Kabi. This prescription-only capsule formulation is supplied as 3 strips of 10 capsules (3×10) per box, providing a total of 30 capsules per package.
Thalidomide is indicated for use in combination therapy for multiple myeloma and for managing skin symptoms associated with lepra reactions. As a controlled prescription medicine, Thalix is intended for distribution exclusively through licensed healthcare channels, including hospitals, oncology clinics, pharmacies, and authorized pharmaceutical importers.
Gravity Global Export supplies Thalix Capsules in export-ready packaging with documentation to support compliant international wholesale shipment. We work with registered distributors, hospital procurement teams, and import-license holders to facilitate cross-border supply of oncology medicines.
Each batch is sourced through authorized channels to support product traceability and consistency for professional buyers. Availability, lead time, and shipping terms vary by destination.
Contact Gravity Global Export today to request a quotation for Thalix 50 mg Capsules and discuss your wholesale oncology product requirements.
Interested in this product?
Tell us your quantity and destination — our export team replies with a competitive quotation.